ECM
AZN icon

Element Capital Management’s AstraZeneca AZN Stock Holding History

Element Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,340
Closed -$2.13M – 294
2019
Q1 		$2.13M Buy
+26,340
New +$2.08M 0.06% 249

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Element Capital Management's AZN Position: Q2 2019 in Review

Element Capital Management sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 26,340 shares — an estimated $2.13M sold.

Element Capital Management first reported a position in AZN in Q1 2019 and held it in 1 quarter. The position peaked at $2.13M in Q1 2019. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

  • Element Capital Management reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
  • Element Capital Management sold 26,340 AstraZeneca shares in Q2 2019, an estimated $2.13M.
  • Element Capital Management first reported a position in AstraZeneca in Q1 2019 and held it in 1 quarter.
  • Element Capital Management's AstraZeneca position peaked at $2.13M in Q1 2019.
  • 546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.